Shanghai Haohai Biological Technology Co. Ltd Cash Flow Reinvestment Rate
Shanghai Haohai Biological Technology Co. Ltd cash flow reinvestment rate. Shanghai Haohai Biological Technology Co. Ltd (5HB) has a Cash Flow Reinvestment Rate of 1.04x as of June 2023, reinvesting €147.33 Million (capex €53.01 Million plus investments €-94.32 Million) from operating cash flow of €141.99 Million. Explore debt repayment capacity of Shanghai Haohai Biological Technology Co to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Shanghai Haohai Biological Technology Co. Ltd (2016–2025)
Cash flow reinvestment rate of Shanghai Haohai Biological Technology Co. Ltd from 2016 to 2025. Historical reinvestment intensity for Shanghai Haohai Biological Technology Co. Ltd across 10 annual periods. Explore 5HB capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Shanghai Haohai Biological Technology Co. Ltd Cash Flow Reinvestment Rate by Year (2016–2025)
Shanghai Haohai Biological Technology Co. Ltd cash flow reinvestment rate by year from 2016 to 2025. Year-by-year capital reinvestment analysis for Shanghai Haohai Biological Technology Co. Ltd. For the full cash flow conversion analysis, see Shanghai Haohai Biological Technology Co (5HB) cash conversion ratio.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.99x | €485.10 Million | €490.97 Million | €186.94 Million | ▼ -32.5% |
| 2024 | 1.46x | €949.62 Million | €648.57 Million | €363.49 Million | ▼ -0.6% |
| 2023 | 1.47x | €934.29 Million | €634.45 Million | €343.10 Million | ▼ -56.2% |
| 2022 | 3.36x | €777.76 Million | €231.30 Million | €309.21 Million | ▲ +255.7% |
| 2021 | 0.95x | €323.55 Million | €342.29 Million | €270.88 Million | ▼ -52.3% |
| 2020 | 1.98x | €519.25 Million | €262.07 Million | €189.70 Million | ▼ -26.2% |
| 2019 | 2.68x | €936.19 Million | €348.91 Million | €249.18 Million | ▲ +37.7% |
| 2018 | 1.95x | €762.61 Million | €391.28 Million | €151.21 Million | ▲ +53.2% |
| 2017 | 1.27x | €436.50 Million | €343.06 Million | €134.29 Million | ▼ -79.6% |
| 2016 | 6.24x | €1.59 Billion | €254.49 Million | €75.67 Million | — |